{
    "nct_id": "NCT04420689",
    "official_title": "Phase 1/2 Trial of ALM-488 in Patients Undergoing Head & Neck Surgery",
    "inclusion_criteria": "1. A neoplasm located in the head and neck.\n2. Primary surgical treatment is by parotidectomy, or thyroidectomy, or cervical neck dissection.\n3. Can understand and is willing to sign a written informed consent document.\n4. â‰¥18 years of age.\n5. Life expectancy of at least 6 months.\n6. Normal liver and kidney functions.\n7. If of childbearing potential, must have a negative urine or serum pregnancy test and be using a medically acceptable form of contraception (e.g., hormonal birth control, intrauterine devices, double-barrier method) or abstinence. The subject, if male, must use a medically acceptable form of contraception (e.g. condom) or abstinence.\n8. Plans to undergo head and neck surgery.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Prior radiation or chemotherapy for any prior head and neck neoplasm.\n2. Open surgery in the ipsilateral head and neck within 1 year.\n3. Abnormal cardiac rhythm not controlled with medication, history of stroke, coronary events and/or heart failure within 1 year.\n4. Current evidence of renal disease.\n5. Pregnant or breastfeeding.\n6. Unresolved acute toxicity from prior anti-cancer therapy.\n7. History of fluorescein allergy.\n8. Any other criteria deemed by the Principal Investigator that may prevent the patient from successfully completing the trial.",
    "miscellaneous_criteria": ""
}